阿尔茨海默病相关的神经丝蛋白的早期诊断价值

尹黎英;袁慧欣;张冀平;师锐赞;李慧媛;胡为民;李国平

武警医学 ›› 2012, Vol. 23 ›› Issue (1) : 10-10.

PDF(437 KB)
PDF(437 KB)
武警医学 ›› 2012, Vol. 23 ›› Issue (1) : 10-10.
论著

阿尔茨海默病相关的神经丝蛋白的早期诊断价值

  • 尹黎英1,袁慧欣1,张冀平1,师锐赞2,李慧媛1,胡为民2,李国平1
作者信息 +

A study of AD7C-NTP levels in urine of patients with Alzheimer disease

Author information +
文章历史 +

摘要

目的 探讨一种简便、可靠、无损伤、特异性较强的早期诊断阿尔茨海默病(alzheimer disease,AD)的方法。

Abstract

Objective To study the value of urine AD7c-NTP levels for the early diagnosis of Alzheimer disease (AD). Methods Using enzyme linked immunosorbent assay (ELISA), the urine AD7c-NTP level was determined and compared: (1)Thirty-eight patients with dementia & 35 age-matched healthy persons; (2) the levels of urine AD7c-NTP & the scores of MMSE, CDR, ADL. Results The urine AD7c-NTP of AD group and the normal group were(90.78±16.54)ng/ml,(70.63±12.56)ng/ml, respectively. Compared with the normal mental group, the levels of urine AD7c-NTP in AD group were significantly increased (P<0.05), which was negatively correlated with the scores of MMSE (the examination of mental state), CDR (clinical dementia rating scale) and ADL (activities of daily living scale).The correlations between AD7c-NTP and MMSE (r=0.756), AD7c-NTP and CDR (r=-0.658), and AD7c-NTP and ADL (r=-0.760)were significant in AD patients (all P<0.01).Conclusions Urine AD7c-NTP levels may be an important biochemical marker for the early diagnosis and condition assessment of AD.

关键词

阿尔茨海默病 / 神经丝蛋白 / 智能精神状态检查量表 / 临床痴呆评定量表 / 日常生活能力量表

引用本文

导出引用
尹黎英;袁慧欣;张冀平;师锐赞;李慧媛;胡为民;李国平. 阿尔茨海默病相关的神经丝蛋白的早期诊断价值[J]. 武警医学. 2012, 23(1): 10-10
A study of AD7C-NTP levels in urine of patients with Alzheimer disease[J]. Medical Journal of the Chinese People Armed Police Forces. 2012, 23(1): 10-10

参考文献

[1] Zhang Z X, Zahner G E, Román G C, et al. Socio-de mographic variation of dementia subtypes in china: methodology and results of a prevalence study in Beijing, Chengdu, Shanghai, and Xian [J]. Neuroepidemiology, 2006, 27(4):177-187.
[2] Diniz B S, Pinto Júnior J A, Forlenza O V. Do CSF total tau, phosphorylated tau, and beta-amyloid 42 help to predict progression of mild cognitive impairment to Alzheimer's disease? A systematic review and meta-analysis of the literature [J]. World J Biol Psychiatry, 2008, 9(3):172-182.
[3] De la Monte S M, Wands J R. Neurodegeneration changes in primary central nervous system neurons transfected with the Alzheimer-associated neuronal thread protein gene [J]. Cell Mol Life Sci, 2001, 58(5-6): 844-849.
[4] World Health Organization. The ICD-10 Classification of Mental and Behavioural Disorders: Clinical Descriptions and Diagnostic Guidelines.1992.
[5] Forlenza O V, Diniz B S, Gattaz W F. Diagnosis and biomarkers of predementia in Alzheimer's disease [J]. BMC Med, 2010, 8: 89.
[6] Munzar M, Levy S, Rush R, et al. Clinical study of a urinary competitve ELISA for neural thread protein in Alzheimer disease [J]. Neurol Clin Neurophysiol, 2002 (1): 2-8.
[7] 刘映红, 胡为民. 老年性痴呆和轻度认知障碍患者尿液中AD7C-NTP的研究[D]. 太原:山西医科大学, 2009.
[8] 闫 鹏,王 蓉,杜怡峰,等. 老年性痴呆患者尿中AD7c-NTP含量的研究[J].山东大学学报,2009,47(6):106-109.
[9] Goodman I, Golden G, Flitman S, et al. A multi-center blinded prospective study of urine neural thread protein measurements in patients with suspected Alzheimer's disease [J]. J Am Med Dir Assoc, 2007, 8(1): 21-30.

PDF(437 KB)

Accesses

Citation

Detail

段落导航
相关文章

/